We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

169 hedge funds and large institutions have $794M invested in Natus Medical Inc in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 55

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

1% less funds holding

Funds holding: 170169 (-1)

3% less capital invested

Capital invested by funds: $818M → $794M (-$23.9M)

Holders
169
Holders Change
-1
Holders Change %
-0.59%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
67
Reduced
55
Closed
18
Calls
$47K
Puts
Net Calls
+$47K
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Nordea Investment Management
26
Nordea Investment Management
Sweden
$5.45M -$43.8K -1,720 -0.8%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$5.34M +$161K +6,324 +3%
Prudential Financial
28
Prudential Financial
New Jersey
$5.28M -$1.45M -56,715 -21%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$5.08M +$933K +36,622 +22%
CIM
30
Confluence Investment Management
Missouri
$4.53M +$31.3K +1,230 +0.7%
RA
31
Royce & Associates
New York
$4.52M -$54.4K -2,137 -1%
Bank of America
32
Bank of America
North Carolina
$4.42M +$985K +38,654 +28%
Morgan Stanley
33
Morgan Stanley
New York
$4.21M -$838K -32,886 -16%
AllianceBernstein
34
AllianceBernstein
Tennessee
$3.95M -$40K -1,570 -1%
PPA
35
Parametric Portfolio Associates
Washington
$3.83M +$363K +14,242 +10%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$3.01M -$501K -19,649 -14%
LIP
37
Liontrust Investment Partners
United Kingdom
$2.81M +$2.85M +112,040 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$2.62M -$323K -12,682 -11%
RCM
39
Rutabaga Capital Management
Massachusetts
$2.52M -$401K -15,750 -14%
DCM
40
DAFNA Capital Management
California
$2.4M
Legal & General Group
41
Legal & General Group
United Kingdom
$2.38M +$177K +6,931 +8%
Axa
42
Axa
France
$2.27M +$1.56M +61,221 +210%
MAM
43
Martingale Asset Management
Massachusetts
$2.21M +$606K +23,801 +37%
BCC
44
Bridge City Capital
Oregon
$2.12M -$573K -22,508 -21%
PAM
45
Panagora Asset Management
Massachusetts
$1.97M +$565K +22,188 +39%
GC
46
Globeflex Capital
California
$1.95M -$1.29M -50,480 -39%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.87M
New York State Teachers Retirement System (NYSTRS)
48
New York State Teachers Retirement System (NYSTRS)
New York
$1.85M +$14.7K +577 +0.8%
Public Sector Pension Investment Board (PSP Investments)
49
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.84M +$94.5K +3,709 +5%
CGFI
50
Cypress Growth Fund III
California
$1.76M

NTUS Hedge Fund Activity: Q3 2021 in Review

169 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2021, worth a combined $794M — down 2.9% from $818M a quarter earlier.

Fund positioning in NTUS was balanced in Q3 2021: 18 funds opened new positions, 18 closed out, 67 added to existing stakes and 55 trimmed.

The largest buyer was Wells Fargo, adding an estimated $2.91M. The largest seller was Fenimore Asset Management, exiting entirely with an estimated $2.61M sold.

  • 169 institutional investors held Natus Medical Inc (NTUS) as of Q3 2021, down from 170 in Q2 2021.
  • Funds reported $794M of Natus Medical Inc stock for Q3 2021, down 2.9% quarter-over-quarter.
  • 18 funds opened new Natus Medical Inc positions in Q3 2021 and 18 closed out, a net change of 0 holders.
  • The largest Natus Medical Inc buyer in Q3 2021 was Wells Fargo, an estimated $2.91M added.
  • The largest Natus Medical Inc seller in Q3 2021 was Fenimore Asset Management, an estimated $2.61M sold.

Based on aggregated 13F filings for Q3 2021.